Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

  • There is currently no data for BIOM

Trading Update

25 Apr 2013 07:00

RNS Number : 1743D
Biome Technologies PLC
25 April 2013
 



25 April 2013

 

Biome Technologies plc

("Biome", "the Company" or "the Group")

 

Trading Update

 

In advance of its Annual General Meeting today, Biome Technologies plc is pleased to announce its trading update for the three months ended 31 March 2013.

 

Trading Update

Total Group revenues achieved for the first three months of the year were £0.4m (Q1 2012: £4.6m including contributions from Biotec). We anticipate performance this year to be second half weighted and consequently expect sales growth to increase in both divisions as the year progresses.

 

The Group's cash position at 31st March 2013 was £5.8m (31st December 2012: £6.3m).

 

We continue to make progress with the strategy, as set out at our full year results, to commercialise and develop wholly owned intellectual property. and our performance remains in line with the Board's expectations.

 

Bioplastics Division

Q1 2013 revenues were £0.2m (Q1 2012: £4.3m including contributions from Biotec). This division is focused on developing high margin, application led products with enhanced level of functionality. Two key projects currently being undertaken include single use foodservice products and single use coffee capsules. These projects are progressing well and their contribution to revenues will become clearer during the second half of the year when they are expected to pass into a predominantly manufacturing phase.

 

In the first quarter, the division was awarded a grant by the Government-backed Technology Strategy Board (TSB) to investigate a bio-based alternative for the oil derived organic chemicals used in the manufacture of bioplastics. The £150,000 grant has been made to Biome Technologies as part of the TSB's 'Sustainable high value chemical manufacture through industrial biotechnology' competition, which funds projects that apply sustainable biobased feedstocks and biocatalytic processes for the production of chemicals. Biome has partnered with the University of Warwick's Centre for Biotechnology and Biorefining to work on the feasibility study that will be funded by this grant.

 

Stanelco RF Technologies Division

Q1 revenues were £0.2m (Q1 2012: £0.3m). This Division continues to see a wider variety of opportunities opening up as the business develops. As previously reported, a number of optical fibre furnace deliveries have been delayed due to some uncertainties in the Chinese fibre market although this market is expected to return to growth during the course of the year. Progress continues on the Durapipe project and the timing of delivery for ten pre-production units will be finalised over the next quarter, following time-based testing of the final pipe-work.

 

Stephen Baskerville, will be joining the Group to head up the Division as its Managing Director in August. Stephen joins the business following some twenty years in technical and commercial roles within the industry, most recently as Director of Heating Products at Inductotherm Heating and Welding Limited, a subsidiary of the global Inductotherm Group.

 

 

- Ends -

 

 

 

For further information please contact:

 

Biome Technologies plc

Paul Mines, Chief Executive Officer

www.biometechnologiesplc.com Tel: +44 (0) 2380 867 100

 

 

Daniel Stewart & Company plc

David Hart

www.danielstewart.co.uk Tel: +44 (0) 20 7776 6550

 

First Columbus

Chris Crawford/Kelly Gardiner

www.first-columbus.com Tel: +44 (0) 20 3002 2070

 

 

FTI Consulting

Oliver Winters/Latika Shah Tel: +44 (0) 20 7831 3113

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTNKQDKFBKDDQB
Date   Source Headline
2nd Jul 20087:00 amRNSTotal Voting Rights
16th Jun 20082:56 pmRNSHolding(s) in Company
16th Jun 20087:00 amRNSHolding(s) in Company
10th Jun 20085:36 pmRNSHolding(s) in Company
4th Jun 20087:00 amRNSAdditional Listing
14th May 20088:53 amRNSDirector/PDMR Shareholding
7th May 20089:51 amRNSDirectors Dealing
7th May 20087:00 amRNSLicense Agreement
1st May 20085:27 pmRNSDirector's Dealings
28th Apr 200811:56 amRNSResult of AGM
28th Apr 20087:00 amRNSAGM and IMS
25th Apr 20083:06 pmRNSDirector/PDMR Shareholding
7th Apr 20084:41 pmRNSSecond Price Monitoring Extn
7th Apr 20084:35 pmRNSPrice Monitoring Extension
7th Apr 20087:00 amRNSAnnual Information Update
2nd Apr 20087:00 amRNSPosting of Annual Report
14th Mar 20087:01 amRNSPreliminary Results
6th Mar 20082:35 pmRNSHolding(s) in Company
3rd Mar 20085:21 pmRNSHolding(s) in Company
29th Feb 20089:43 amRNSSpeculation re plastics
18th Feb 20084:40 pmRNSSecond Price Monitoring Extn
18th Feb 20084:35 pmRNSPrice Monitoring Extension
7th Feb 20084:13 pmRNSNotifiable Interest
4th Feb 200810:25 amRNSHolding(s) in Company
1st Feb 200811:40 amRNSHolding(s) in Company
30th Jan 20084:20 pmRNSNotifiable Interest
30th Jan 20087:01 amRNSNotifiable Interest
28th Jan 200811:22 amRNSNotifiable Interest
21st Jan 20083:27 pmRNSNotifiable Interest
17th Jan 20083:40 pmRNSNotifiable Interest
15th Jan 20084:40 pmRNSSecond Price Monitoring Extn
15th Jan 20084:35 pmRNSPrice Monitoring Extension
15th Jan 20082:28 pmRNSNotifiable Interest
14th Jan 20087:00 amRNSPre Close Update
9th Jan 20084:25 pmRNSHolding(s) in Company
4th Dec 20074:40 pmRNSSecond Price Monitoring Extn
4th Dec 20074:35 pmRNSPrice Monitoring Extension
26th Nov 20074:35 pmRNSPrice Monitoring Extension
25th Sep 20079:54 amRNSNotifiable Interest
10th Sep 20077:02 amRNSInterim Results
28th Aug 20072:33 pmRNSNotifiable Interest
30th Jul 20074:37 pmRNSNotifiable Interest
30th Jul 20074:35 pmRNSNotifiable Interest
27th Jul 20071:56 pmRNSNotifiable Interest
6th Jul 20077:01 amRNSTrading Statement
5th Jul 20076:19 pmRNSDirector Dealings
29th Jun 200712:26 pmRNSTotal Voting Rights
6th Jun 20074:14 pmRNSAdditional Listing
29th May 20075:29 pmRNSDisposal of Assets
29th May 20077:02 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.